Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1150 of 3284 entries
View as:

Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users

Phase: N/A Priority: Normal
NCT ID: NCT06594068 Org: User:
Start: 08/29/25 End: 08/31/27 Due: 08/31/28

A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

Phase: N/A Priority: Normal
NCT ID: NCT06862791 Org: User:
Start: 02/18/25 End: 06/18/26 Due: 06/18/27

Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.

Phase: N/A Priority: Normal
NCT ID: NCT02000622 Org: User:
Start: 03/27/14 End: 12/31/25 Due: 12/31/26

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00605267 Org: User:
Start: 10/31/07 End: 12/31/10 Due: 12/31/11

National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups

Phase: N/A Priority: Normal
NCT ID: NCT00699959 Org: User:
Start: 06/30/08 End: 01/31/09 Due: 01/31/10

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT01197508 Org: User:
Start: 09/30/10 End: 01/31/12 Due: 01/31/13

To Assess Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses.

Phase: N/A Priority: Normal
NCT ID: NCT01958645 Org: User:
Start: 11/30/13 End: 10/31/14 Due: 10/31/15

ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00929162 Org: User:
Start: 06/30/09 End: 06/30/11 Due: 06/30/12

China Registration Study in Patients With Skin Infections

Phase: N/A Priority: Normal
NCT ID: NCT00772447 Org: User:
Start: 09/30/08 End: 09/30/10 Due: 09/30/11

Open Label Study, Assessing the Effect of Diltiazem or Ketoconazole on the Pharmacokinetics of AZD9742 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01124760 Org: User:
Start: 05/31/10 End: 07/31/10 Due: 07/31/11

Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT03084965 Org: User:
Start: 05/12/17 End: 03/02/18 Due: 03/02/19

Safety and Tolerability of AZD5148 in Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06639997 Org: User:
Start: 10/31/24 End: 01/19/26 Due: 01/19/27

Study of AZD9829 in CD123+ Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06179511 Org: User:
Start: 01/31/24 End: 01/07/27 Due: 01/07/28

Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00241475 Org: User:
Start: 12/31/03 End: 10/31/05 Due: 10/31/06

CMAB vs IMAB in Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00255268 Org: User:
Start: 08/31/04 End: - Due: -

Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT02475720 Org: User:
Start: 06/19/15 End: 03/16/16 Due: 03/16/17

ALEXANDRIA Study Egypt

Phase: N/A Priority: Normal
NCT ID: NCT03583463 Org: User:
Start: 10/29/18 End: 01/24/21 Due: 01/24/22

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00075959 Org: User:
Start: 08/31/04 End: 01/31/06 Due: 01/31/07

A Study of the Effect of Patient Education (Talking Health Together) in Improving Doctor-patient Communication

Phase: N/A Priority: Normal
NCT ID: NCT00879736 Org: User:
Start: 03/31/09 End: 08/31/10 Due: 08/31/11

Real-world Dapagliflozin Treatment in Patients With Heart Failure in Portugal (EVOLUTION-HF)

Phase: N/A Priority: Normal
NCT ID: NCT05465213 Org: User:
Start: 11/28/22 End: 06/24/24 Due: 06/24/25

OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain

Phase: N/A Priority: Normal
NCT ID: NCT06068049 Org: User:
Start: 07/28/23 End: 06/15/29 Due: 06/15/30

Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT06203704 Org: User:
Start: 12/20/23 End: 09/30/25 Due: 09/30/26

Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%

Phase: N/A Priority: Normal
NCT ID: NCT04986202 Org: User:
Start: 06/30/21 End: 03/27/24 Due: 03/27/25

A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the Body

Phase: N/A Priority: Normal
NCT ID: NCT04187456 Org: User:
Start: 12/27/19 End: 03/06/20 Due: 03/06/21

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00753896 Org: User:
Start: 10/31/08 End: 11/30/09 Due: 11/30/10